An α-specific PI3K inhibitor improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancer.

Journal:

Hepatology

Published:

2025-12-16

DOI:

10.1097/hep.0000000000001639

Affiliations:

6

Authors:

16

Go to article

Institutions	Authors	Share
The University of Queensland (UQ), Australia	6.000000	0.38
Greenslopes Private Hospital, Australia	4.750000	0.30
Mater Research Institute - University of Queensland (MRI-UQ), Australia	3.000000	0.19
Renji Hospital, SJTU, China	2.000000	0.13
The Prince Charles Hospital (TPCH), Australia	0.250000	0.02

Interested in Oncology and Carcinogenesis?